Low-dose non-targeted effects and mitochondrial control

D Averbeck - International Journal of Molecular Sciences, 2023 - mdpi.com
Non-targeted effects (NTE) have been generally regarded as a low-dose ionizing radiation
(IR) phenomenon. Recently, regarding long distant abscopal effects have also been …

[HTML][HTML] Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response

E McCann, J O'Sullivan, S Marcone - Translational oncology, 2021 - Elsevier
Radiotherapy is a regimen that uses ionising radiation (IR) to treat cancer. Despite the
availability of several therapeutic options, cancer remains difficult to treat and only a minor …

Mitochondrial control of genomic instability in cancer

M Bonora, S Missiroli, M Perrone, F Fiorica, P Pinton… - Cancers, 2021 - mdpi.com
Simple Summary Cancer cells display among its hallmark genomic instability. This is a
progressive tendency in accumulate genome alteration which contributes to the damage of …

Energy metabolism is altered in radioresistant rectal cancer

CE Buckley, X Yin, S Meltzer, AH Ree… - International Journal of …, 2023 - mdpi.com
Resistance to neoadjuvant chemoradiation therapy is a significant clinical challenge in the
management of rectal cancer. There is an unmet need to identify the underlying …

MicroRNA profiling in oesophageal adenocarcinoma cell lines and patient serum samples reveals a role for miR-451a in radiation resistance

F Butz, AK Eichelmann, GC Mayne, T Wang… - International journal of …, 2020 - mdpi.com
Many patients with Oesophageal Adenocarcinoma (OAC) do not benefit from
chemoradiotherapy treatment due to therapy resistance. To better understand the …

Opposing Immune-Metabolic Signature in Visceral Versus Subcutaneous Adipose Tissue in Patients with Adenocarcinoma of the Oesophagus and the …

AB Heeran, J McCready, MR Dunne, NE Donlon… - Metabolites, 2021 - mdpi.com
Oesophageal adenocarcinoma (OAC) is an exemplar model of obesity-associated cancer.
Previous work in our group has demonstrated that overweight/obese OAC patients have …

30th Annual GP2A Medicinal Chemistry Conference

NM O'boyle, JJ Helesbeux, MJ Meegan, A Sasse… - 2023 - mdpi.com
The Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A) held their
30th annual conference in August 2022 in Trinity College Dublin, Ireland. There were 9 …